disulfiram has been researched along with Medulloblastoma in 1 studies
Medulloblastoma: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Serra, R | 1 |
Zhao, T | 1 |
Huq, S | 1 |
Gorelick, NL | 1 |
Casaos, J | 1 |
Cecia, A | 1 |
Mangraviti, A | 1 |
Eberhart, C | 1 |
Bai, R | 1 |
Olivi, A | 1 |
Brem, H | 1 |
Jackson, EM | 1 |
Tyler, B | 1 |
1 other study available for disulfiram and Medulloblastoma
Article | Year |
---|---|
Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model.
Topics: Aldehyde Dehydrogenase; Animals; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Proliferation; Copper; | 2021 |